Lidocaine patch 5%

Drugs

Volumn 59, Issue 2, 2000, Pages 245-249

  Comer, Alison M ^a   Lamb, Harriet M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE;

ALLODYNIA; ANALGESIC ACTIVITY; ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; NONHUMAN; PAIN; PHARMACODYNAMICS; POSTHERPETIC NEURALGIA; RASH; REVIEW; SKIN IRRITATION; TRANSDERMAL PATCH;

EID: 0034106570     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059020-00006     Document Type: Review

References (21)

1. 1. Bowsher D. The management of postherpetic neuralgia. Postgrad Med J 1997 Oct; 73: 623-9
2. 2. Kost RG, Straus SE. Postherpetic neuralgia - pathogenesis, treatment, and prevention. N Engl J Med 1996 Jul 4; 335: 32-42
3. 3. Hanania MM, Brietstein D. Postherpetic neuralgia: a review. Cancer Invest 1997; 15 (2): 165-76
4. 4. Watson CP, Deck JH, Morshead C, et al. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991 Feb; 44 (2): 105-17
5. 5. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991 Jul; 41: 1024-8
6. 6. Baranowski AP, DeCourcey J, Bonello E. A trial of intravenous lidocaine on the pain and allodynia of postherpetic neuralgia. J Pain Symptom Manage 1999; 17 (6): 429-33
7. 7. Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995; 37 (2): 246-53
8. 8. Rowbotham MC, Fields HL. Topical lidocaine reduces pain in post-herpetic neuralgia. Pain 1989; 38 (3): 297-301
9. 9. Kissin I, McDanal J, Xavier AV. Topical lidocaine for relief of superficial pain in postherpetic neuralgia. Neurology 1989; 39 (8): 1132-3
10. 10. Rowbotham MC, Fields HL. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature. Pain 1989; 39 (2): 129-44
11. 11. Endo Pharmaceuticals Inc. Lidoderm package insert. Chadds Ford (PA), 1999
12. 12. Galer BS, Devers A, Portenoy R, et al. Topical lidocaine patch relieves a variety of peripheral neuropathic pains: an open label experience [abstract]. 9th World Congr Pain 1999 Aug 22: 69
13. 13. Ritchie JM, Greene NM. Local anaesthetics. In: Gilman AG, Rall TW, Nies AS, et al., editors. The pharmacological basis of therapeutics. 8th ed. Singapore: McGraw-Hill, Inc., 1992: 311-31
14. 14. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produces a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985; 23 (4): 361-74
15. 15. Chabal C, Russell LC, Burchiel KJ. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain 1989; 38 (3): 333-8
16. 16. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992; 48 (2): 261-8
17. 17. Benowitz NL, Meister W. Clinical pharmacokinetics of lignocaine. Clin Pharmacokinet 1978; 3: 177-201
18. 18. Wilson JD, Braunwald E, Isselbacher KJ, et al., editors. Harrison's principals of internal medicine. 12th ed. vol 1. New York: McGraw-Hill, Inc, 1991
19. 19. Rowbotham MC, Davie.s PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996 Apr; 65: 39-44
20. 20. Galer BS, Rowbotham MC, Perander J. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999 Apr; 80: 533-8
21. 21. Rowbotham MC, Davies PS, Galer BS. Multicenter, double-blind, vehicle-controlled trial of long term use of lidocaine patches for postherpetic neuralgia [abstract]. In: 8th World Congress on Pain - Abstracts. Seattle (WA): IASP Press, 1996: 274